Moreover, in vitro treatment with bortezomib was also able to increase the expression of MICA/B, Nectin-2, and PVR expression on MM cells enhancing the sensitivity of MM cells to NK cell-mediated lysis [215] (Figure 4E). This evidence concerns the gene NECTIN2 and Miyoshi myopathy.